A monoacylglycerol lipase from Mycobacterium smegmatis Involved in bacterial cell interaction.
MSMEG_0220 from Mycobacterium smegmatis, the ortholog of the Rv0183 gene from M. tuberculosis, recently identified and characterized as encoding a monoacylglycerol lipase, was cloned and expressed in Escherichia coli. The recombinant protein (rMSMEG_0220), which exhibits 68% amino acid sequence identity with Rv0183, showed the same substrate specificity and similar patterns of pH-dependent activity and stability as the M. tuberculosis enzyme. rMSMEG_0220 was found to hydrolyze long-chain monoacylglycerol with a specific activity of 143 +/- 6 U mg(-1). Like Rv0183 in M. tuberculosis, MSMEG_0220 was found to be located in the cell wall. To assess the in vivo role of the homologous proteins, an MSMEG_0220 disrupted mutant of M. smegmatis (MsDelta0220) was produced. An intriguing change in the colony morphology and in the cell interaction, which were partly restored in the complemented mutant containing either an active (ComMsDelta0220) or an inactive (ComMsDelta0220S111A) enzyme, was observed. Growth studies performed in media supplemented with monoolein showed that the ability of both MsDelta0220 and ComMsDelta0220S111A to grow in the presence of this lipid was impaired. Moreover, studies of the antimicrobial susceptibility of the MsDelta0220 strain showed that this mutant is more sensitive to rifampin and more resistant to isoniazid than the wild-type strain, pointing to a critical structural role of this enzyme in mycobacterial physiology, in addition to its function in the hydrolysis of exogenous lipids.
Dhouib
Rabeb
R
CNRS, Aix-Marseille Université, Enzymologie Interfaciale et Physiologie de la Lipolyse UPR 9025, 31 chemin Joseph Aiguier, 13402 Marseille cedex 20, France.
Laval
Françoise
F
Carrière
Frédéric
F
Daffé
Mamadou
M
Canaan
Stéphane
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D015153:Blotting, Western; D002701:Chloramphenicol / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D005816:Genetic Complementation Test; D006863:Hydrogen-Ion Concentration; D008826:Microbial Sensitivity Tests; D008994:Monoacylglycerol Lipases / Q000235:genetics / Q000378:metabolism*; D020102:Mycobacterium smegmatis / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics; D009675:Novobiocin / Q000494:pharmacology; D012293:Rifampin / Q000493:pharmacokinetics; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013379:Substrate Specificity
D000900:Anti-Bacterial Agents; D009675:Novobiocin; D002701:Chloramphenicol; D008994:Monoacylglycerol Lipases; D012293:Rifampin